Skip to main content
OpenTrials

Clinical trial condition

Neurodevelopmental Disorders

Explore clinical trials studying Neurodevelopmental Disorders. Study availability and eligibility vary by location and protocol.

4,081 public trials 628 recruiting studies
Refine in advanced search Browse all conditions

Neurodevelopmental Disorders trial results

Completed

SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms

NCT00367835

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • HOPE Research Institute Phoenix, Arizona, United States
  • Valley Clinical Research El Centro, California, United States
  • Peninsula Research Associates Inc Rolling Hills Estates, California, United States
  • Sarkis Clinical Trials Gainesville, Florida, United States
View all 34 locations
View Trial Details
Completed

Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

NCT01081145

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
Locations
  • Harmonex Neuroscience Research Dothan, Alabama, United States
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Psychiatric Centers at San Diego, Feighner Research San Diego, California, United States
  • Encompass Clinical Research - North Coast Spring Valley, California, United States
View all 81 locations
View Trial Details
Completed

Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17

NCT00763971

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • ZiekenhuisNetwerk Antwerpen, Commandant Weynsstraat 165, Campus Hoge Beuken Hoboken, Antwerp, Belgium
  • Universitair Ziekenhuis Gent, Kinder-en Jeugdpsychiatrie, De Pintelaan 185 Ghent, East Flanders, Belgium
  • Afdeling Psychiatrie, UZ Herestraat 49, Bus 07003 Leuven, Belgium
  • Hospital Archet 2 Nice, Cedex 03, France
View all 49 locations
View Trial Details
Completed

Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study

NCT00764868

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Valley Clinical Research, Inc. El Centro, California, United States
  • Penninsula Research Associates, Inc. Rolling Hills Estates, California, United States
  • Psychiatric Centers at San Diego (PCSD-Feighner Research Institute) San Diego, California, United States
View all 45 locations
View Trial Details
Completed

Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate

NCT01106430

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
Locations
  • Harmonex Neuroscience Research, Inc Dothan, Alabama, United States
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Shanti Clinical Trials Colton, California, United States
  • Psychiatric Centers at San Diego Feighner Research San Diego, California, United States
View all 64 locations
View Trial Details

Related conditions